Europe Clinical Trials Support Services Market 2022-2028
MARKET OUTLOOK
Triton Market Research’s study estimates the clinical trials support services market in Europe to grow with a CAGR of 8.15% during the forecast years 2022-2028. Italy, Spain, Germany, the United Kingdom, France, and Rest of Europe are analyzed in the market in this region.
Countries like Poland, Ireland, Austria, Switzerland, and others, are covered under Rest of Europe. In Poland, the number of clinical trials being performed has increased significantly. For instance, from 2000 to 2019, 1840 clinical trials took place in Poland. The increase in the number of trials also increases the amount of data generated. This calls for the adoption of support services such as data management, data processing, data analysis, etc. The increased use of support services is expected to drive the growth of the studied market in Poland, and, in turn, in Rest of Europe.
Spain ranks first in Europe and fourth in the world in terms of conducting clinical trials. The collaboration between the private and public sectors has contributed in making the country a leading name in the clinical trials sector. 1,019 trials were approved in 2020, of which 34% share was captured by medicines for treating various types of cancer. The major factor driving successful clinical trials is the involvement of an increasing number of patients in the trial process. For instance, in 2021, nearly 145,000 patients participated in more than 3,400 ongoing clinical trials in Spain.
COMPETITIVE OUTLOOK
The noteworthy players in the clinical trials support services market include IQVIA, ICON Plc, CTI Clinical Trial and Consulting Services Inc, Charles River Laboratories, PSI CRO, WuXi AppTec, Worldwide Clinical Trials, and Parexel.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook